$18.54
0.492.71%
Last update: Nov 4, 4:29 PM
Dyne Therapeutics Inc (DYN) Stock Price, Quote, News & History
DYNNASDAQ
Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.
You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.
Other companies in Dyne Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Dyne Therapeutics has a consensus price target of $36.95.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $18.45 last updated November 4, 2026 at 4:29 PM EST.
There are no upcoming dividends for Dyne Therapeutics.
Dyne Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted...
